Google DeepMind launched AlphaGenome, an AI tool designed to identify genetic drivers of disease.
The system analyses up to one million DNA letters at once to predict how mutations affect gene regulation.
AlphaGenome focuses on the non-coding genome, which controls when and where genes activate.
Researchers trained the model on large human and mouse genetics databases.
Scientists believe the tool could accelerate cancer research and rare disease diagnosis.
AlphaGenome may also support new gene therapies by helping design targeted DNA sequences.
Trending
- K2G Holding brings in former Simpego CEO to drive expansion strategy
- Walking Mistakes Guide You Should Fix Today
- Met Gala Bathroom Challenge Stuns Celebrities
- Thunder Lakers Game 1 Ends in Big OKC Win
- California Remote Teaching Bill Sparks Debate
- Houston Family Tragedy Leaves Community in Shock
- Ohio Daycare Abuse Case Ends in Prison Sentence
- Endangered Species Recovery Shows Strong Growth
Google DeepMind Unveils AlphaGenome to Decode Genetic Causes of Disease
Andrew Rogers
Andrew Rogers is a freelance journalist based in Chicago, USA, with over 10 years of experience covering Politics, World Affairs, Business, Health, Technology, Finance, Lifestyle, and Culture. He graduated with a degree in Journalism from the University of Florida. Over the years, he has contributed to leading outlets such as The New York Times, CNN, and Reuters. Recognized for his sharp reporting and thoughtful analysis, Andrew delivers accurate and timely news that keeps readers updated on key national and global developments.
Add A Comment